MedPath

Hangzhou Dinova EP Technology Co.,Ltd.

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

An Exploratory Study of Focal Pulse Ablation System in the Treatment of Atrial Arrhythmia

Not Applicable
Recruiting
Conditions
Atrial Fibrillation (AF)
Typical Atrial Flutter
Interventions
Device: Focal Pulse field Ablation
First Posted Date
2023-12-05
Last Posted Date
2025-02-11
Lead Sponsor
Hangzhou Dinova EP Technology Co., Ltd
Target Recruit Count
10
Registration Number
NCT06157437
Locations
🇨🇳

Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China

Evaluation of the Safety and Efficacy of a Novel SeaLA™ Left Atrial Appendage Occluder

Not Applicable
Active, not recruiting
Conditions
Atrial Fibrillation
Interventions
Device: SeaLA™ left atrial appendage occluder
First Posted Date
2023-06-22
Last Posted Date
2023-06-27
Lead Sponsor
Hangzhou Dinova EP Technology Co., Ltd
Target Recruit Count
163
Registration Number
NCT05911685
Locations
🇨🇳

General Hospital of the Northern Theater of the Chinese People's Liberation Army, Shengyang, China

First in Man Study of Left Atrial Appendage Pulsed Field Ablation Occluder

Not Applicable
Recruiting
Conditions
Nonvalvular Atrial Fibrillation
Interventions
Device: E-SeaLA, CardioPulse PFA system
First Posted Date
2023-02-16
Last Posted Date
2024-01-17
Lead Sponsor
Hangzhou Dinova EP Technology Co., Ltd
Target Recruit Count
10
Registration Number
NCT05731882
Locations
🇨🇳

Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China

🇨🇳

Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan, China

🇨🇳

General Hospital of Northern Theater Command, Shenyang, Liaoning, China

Study on the Safety and Effectiveness of the SnowyTM PFO Closure System

Not Applicable
Not yet recruiting
Conditions
Patent Foramen Ovale
Interventions
Device: SnowyTM PFO closure system
Device: Cardi-o-fix PFO occluder
First Posted Date
2022-05-04
Last Posted Date
2023-06-07
Lead Sponsor
Hangzhou Dinova EP Technology Co., Ltd
Target Recruit Count
242
Registration Number
NCT05360771
Locations
🇨🇳

The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

Evaluation of the Safety and Efficacy of the CardioPulseTM PuLsed fiEld Ablation SystEm in Patients With Paroxysmal Atrial Fibrillation (PLEASE-AF Study)

Not Applicable
Completed
Conditions
Paroxysmal Atrial Fibrillation
Interventions
Device: CardioPulsesTM pulsed field ablation system
First Posted Date
2021-11-10
Last Posted Date
2023-06-07
Lead Sponsor
Hangzhou Dinova EP Technology Co., Ltd
Target Recruit Count
158
Registration Number
NCT05114954
Locations
🇨🇳

General Hospital of the Northern Theater of the Chinese People's Liberation Army, Shenyang, China

© Copyright 2025. All Rights Reserved by MedPath